Romiplostim for management of chemotherapy-induced thrombocytopenia

Leukaemic transformation with romiplostim

(2012) Kate Gardner et al.   BRITISH JOURNAL OF HAEMATOLOGY

Diagnosis and Management of Immune Thrombocytopenia in the Era of Thrombopoietin Mimetics

(2011) H. A. Liebman et al.   Hematology-American Society of Hematology Education Program

Biology and Chemistry of Thrombopoietic Agents

(2010) David J. Kuter   SEMINARS IN HEMATOLOGY

Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim

(2009) D. J. Kuter et al.   BLOOD

9209 Safety of romiplostim for treatment of severe chemotherapy induced thrombocytopenia (CIT) in patients with lymphoma receiving multi-cycle chemotherapy: results from an open-label dose- and schedule-finding study

(2009) M. Fanale et al.   EJC SUPPLEMENTS

9248 Safety of romiplostim for treatment of chemotherapy-induced thrombocytopenia (CIT) in patients with advanced non-small cell lung cancer (NSCLC)

(2009) R. Natale et al.   EJC SUPPLEMENTS

Venous Thromboembolism and Mortality Associated With Recombinant Erythropoietin and Darbepoetin Administration for the Treatment of Cancer-Associated Anemia

(2008) Charles L. Bennett   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION